How have YSBPW shares performed in 2024?

YS Biopharma's stock was trading at $0.0380 on January 1st, 2024. Since then, YSBPW shares have increased by 68.4% and is now trading at $0.0640. View the best growth stocks for 2024 here .

Are investors shorting YS Biopharma?

YS Biopharma saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 4,000 shares, an increase of 110.5% from the April 30th total of 1,900 shares. Based on an average daily volume of 40,800 shares, the days-to-cover ratio is presently 0.1 days. View YS Biopharma's Short Interest .

How do I buy shares of YS Biopharma?

Shares of YSBPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:YSBPW

YS Biopharma (YSBPW) Stock Price, News & Analysis

→ Obama’s Forever Term [exposed] (From Porter & Company) (Ad)

Free YSBPW Stock Alerts

$0.06

-0.02 (-23.81%)

(As of 06/7/2024 ET)

Compare

Today's Range: $0.03
▼
$0.08
50-Day Range: $0.07
▼
$0.11
52-Week Range: $0.01
▼
$0.10

Volume: 92,364 shs
Average Volume: 37,227 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Trends

Get YS Biopharma alerts:

Ad Paradigm Press

Time is Running Out - June 25th Deadline Approaching!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

That will slam shut June 25.

About YS Biopharma

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

YSBPW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

YSBPW Stock News Headlines

May 30, 2024 | americanbankingnews.com

Short Interest in YS Biopharma Co., Ltd. (NASDAQ:YSBPW) Grows By 110.5%

See More Headlines

Receive YSBPW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:YSBPW
CUSIP: N/A
CIK: 1946399
Web: www.yishengbio.com
Phone: 86-10-8920-2086
Fax: N/A
Employees: 865
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $560.76 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Hui Shao (Age 54)
Pres, CEO & Exec. Director
Ms. Chunyuan Wu (Age 45)
Chief Financial Officer
Mr. Gang Li (Age 41)
Head of Marketing & Sales
Dr. Zenaida Reynoso Mojares (Age 64)
Chief Medical Officer
Dr. Yuan Liu (Age 36)
Head of Vaccine Research

Key Competitors

View All Competitors

YSBPW Stock Analysis - Frequently Asked Questions

How have YSBPW shares performed in 2024?: YS Biopharma's stock was trading at $0.0380 on January 1st, 2024. Since then, YSBPW shares have increased by 68.4% and is now trading at $0.0640.
View the best growth stocks for 2024 here.
Are investors shorting YS Biopharma?: YS Biopharma saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 4,000 shares, an increase of 110.5% from the April 30th total of 1,900 shares. Based on an average daily volume of 40,800 shares, the days-to-cover ratio is presently 0.1 days.
View YS Biopharma's Short Interest.
How do I buy shares of YS Biopharma?: Shares of YSBPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:YSBPW) was last updated on 6/7/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial